Page last updated: 2024-08-26

bosentan anhydrous and Pulmonary Veno Occlusive Disease

bosentan anhydrous has been researched along with Pulmonary Veno Occlusive Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dorfmuller, P; Humbert, M; Jaïs, X; Montani, D; Simonneau, G; Sitbon, O	1
Cai, Y; Guo, F; Kuang, JL; Yan, CS; Ye, XQ; Zhang, XY	1
Boutou, A; Kontou, P; Paspala, A; Pitsiou, G; Sourla, E; Stanopoulos, I	1

Reviews

1 review(s) available for bosentan anhydrous and Pulmonary Veno Occlusive Disease

Article	Year
Lengthy diagnostic challenge in a rare case of pulmonary veno-occlusive disease: case report and review of the literature. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:12 Topics: Adult; Antihypertensive Agents; Biopsy; Bosentan; Cardiotonic Agents; Diagnosis, Differential; Digoxin; Diuretics; Drug Therapy, Combination; Dyspnea; Humans; Hypertension, Pulmonary; Male; Pulmonary Heart Disease; Pulmonary Veno-Occlusive Disease; Sulfonamides; Time Factors; Tomography, X-Ray Computed	2011

Article

Year

Lengthy diagnostic challenge in a rare case of pulmonary veno-occlusive disease: case report and review of the literature.

Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:12

Topics: Adult; Antihypertensive Agents; Biopsy; Bosentan; Cardiotonic Agents; Diagnosis, Differential; Digoxin; Diuretics; Drug Therapy, Combination; Dyspnea; Humans; Hypertension, Pulmonary; Male; Pulmonary Heart Disease; Pulmonary Veno-Occlusive Disease; Sulfonamides; Time Factors; Tomography, X-Ray Computed

2011

Other Studies

2 other study(ies) available for bosentan anhydrous and Pulmonary Veno Occlusive Disease

Article	Year
Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution. The European respiratory journal, 2009, Volume: 34, Issue:5 Topics: Bosentan; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Middle Aged; Piperazines; Pulmonary Edema; Pulmonary Medicine; Pulmonary Veno-Occlusive Disease; Purines; Risk; Sildenafil Citrate; Sulfonamides; Sulfones; Tomography, X-Ray Computed; Treatment Outcome	2009
A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges. Therapeutic advances in respiratory disease, 2013, Volume: 7, Issue:2 Topics: Adult; Bosentan; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Endothelin Receptor Antagonists; Epoprostenol; Humans; Iloprost; Lung; Lung Transplantation; Male; Piperazines; Pulmonary Artery; Pulmonary Veno-Occlusive Disease; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Tomography, X-Ray Computed; Vasodilator Agents; Waiting Lists	2013

Article

Year

Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution.

The European respiratory journal, 2009, Volume: 34, Issue:5

Topics: Bosentan; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Middle Aged; Piperazines; Pulmonary Edema; Pulmonary Medicine; Pulmonary Veno-Occlusive Disease; Purines; Risk; Sildenafil Citrate; Sulfonamides; Sulfones; Tomography, X-Ray Computed; Treatment Outcome

2009

A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges.

Therapeutic advances in respiratory disease, 2013, Volume: 7, Issue:2

Topics: Adult; Bosentan; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Endothelin Receptor Antagonists; Epoprostenol; Humans; Iloprost; Lung; Lung Transplantation; Male; Piperazines; Pulmonary Artery; Pulmonary Veno-Occlusive Disease; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Tomography, X-Ray Computed; Vasodilator Agents; Waiting Lists

2013